CellCarta acquires Biogazelle to strengthen its genomic capabilities and expand into digital PCR (dPCR) services
This acquisition solidifies CellCarta’s leadership position in genomic services with a unique combination of assay development and global clinical trial sample analysis capabilities covering a comprehensive range of established and cutting-edge genomic technologies. CellCarta, a leading global provider of precision medicine laboratory services, announced today the acquisition of Biogazelle (“Biogazelle”), a leader in genomic…
